Previous Article | Next Article 
Molecular and Cellular Biology, May 1999, p. 3816-3828, Vol. 19, No. 5
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Insulin-Like Growth Factor I Synergizes with
Interleukin 4 for Hematopoietic Cell Proliferation Independent of
Insulin Receptor Substrate Expression
Lilian
Soon,1
Lawrence
Flechner,1
J. Silvio
Gutkind,2
Lu-Hai
Wang,3
Renato
Baserga,4
Jacalyn H.
Pierce,1 and
Weiqun
Li1,*
Laboratory of Cellular and Molecular Biology,
National Cancer Institute,1 and Oral and
Pharyngeal Cancer Branch, National Institute of Dental
Research,2 Bethesda, Maryland 20892;
Department of Microbiology, Mount Sinai School of Medicine,
New York, New York 100293; and The
Kimmel Cancer Center, Thomas Jefferson University, Philadelphia,
Pennsylvania 191074
Received 20 October 1998/Returned for modification 23 November
1998/Accepted 24 February 1999
In the present study, we investigated the potential role of
insulin-like growth factor I (IGF-I) receptor (IGF-IR) in cell proliferation by overexpressing it in 32D myeloid progenitor cells. The
overexpression of IGF-IR caused the transfectants to proliferate in
response to IGF-I in the absence of insulin receptor substrate (IRS)
expression. The activation of overexpressed wild-type IGF-IR, but not
that of an ATP-binding mutant of IGF-IR, resulted in the increased
tyrosine phosphorylation of several intracellular proteins, including
SHC, Src homology 2-containing inositol-5-phosphatase, protein kinase
C-
, and Erk2. Grb2 association with SHC and mitogen-activated protein kinase (MAPK) activity was also enhanced in response to IGF-I
stimulation. Interestingly, the stimulation of the IGF-IR transfectants
with interleukin 4 (IL-4) also resulted in strong mitogenesis
independent of IRS expression. Moreover, IGF-I and/or IL-4 induced
long-term cell growth of the IGF-IR transfectants. IL-4 was able to
synergize with IGF-I for DNA synthesis, even in the parental 32D cells
and a pro-B-cell line, Baf3, indicating the physiological importance of
the two growth factors in hematopoietic cell proliferation. IL-4
stimulation of the IGF-IR transfectants resulted in enhanced tyrosine
phosphorylation of SHC, Erk2, and signal transducer and activator of
transcription 6 (STAT6) proteins. Both IL-4 and IGF-I were able to
induce c-myc early response gene expression, and this
expression was maximal in the presence of both factors. Finally, we
demonstrated that a MAPK kinase inhibitor was able to suppress
mitogenesis of the IGF-IR transfectants in response to IGF-I and/or
IL-4. Together, our results suggest that IL-4 synergizes with IGF-I for
hematopoietic cell proliferation, likely through cross talk between
SHC/Grb2/MAPK and STAT6 pathways and through c-myc gene
up-regulation.
*
Corresponding author. Mailing address: Laboratory of
Cellular and Molecular Biology, National Cancer Institute, Bldg. 37, Room 1E24, 9000 Rockville Pike, Bethesda, MD 20892. Phone: (301) 496-1347. Fax: (301) 496-8479. E-mail:
liwe{at}dc37a.nci.nih.gov.
Molecular and Cellular Biology, May 1999, p. 3816-3828, Vol. 19, No. 5
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lieskovska, J., Ling, Y., Badley-Clarke, J., Clemmons, D. R.
(2006). The Role of Src Kinase in Insulin-like Growth Factor-dependent Mitogenic Signaling in Vascular Smooth Muscle Cells. J. Biol. Chem.
281: 25041-25053
[Abstract]
[Full Text]
-
Baudler, S., Baumgartl, J., Hampel, B., Buch, T., Waisman, A., Snapper, C. M., Krone, W., Bruning, J. C.
(2005). Insulin-Like Growth Factor-1 Controls Type 2 T Cell-Independent B Cell Response. J. Immunol.
174: 5516-5525
[Abstract]
[Full Text]
-
Verras, M., Sun, Z.
(2005). {beta}-Catenin Is Involved in Insulin-Like Growth Factor 1-Mediated Transactivation of the Androgen Receptor. Mol. Endocrinol.
19: 391-398
[Abstract]
[Full Text]
-
Wu, A., Tu, X., Prisco, M., Baserga, R.
(2005). Regulation of Upstream Binding Factor 1 Activity by Insulin-like Growth Factor I Receptor Signaling. J. Biol. Chem.
280: 2863-2872
[Abstract]
[Full Text]
-
Sun, H., Baserga, R.
(2004). Deletion of the Pleckstrin and Phosphotyrosine Binding Domains of Insulin Receptor Substrate-2 Does Not Impair Its Ability to Regulate Cell Proliferation in Myeloid Cells. Endocrinology
145: 5332-5343
[Abstract]
[Full Text]
-
Giron-Michel, J., Fogli, M., Gaggero, A., Ferrini, S., Caignard, A., Brouty-Boye, D., Baouz, S., Le Bousse-Kerdiles, M.-C., Peault, B., van Dijk, M., Bulfone-Paus, S., Durali, D., Chouaib, S., Azzarone, B.
(2003). Detection of a Functional Hybrid Receptor {gamma}c/GM-CSFR{beta} in Human Hematopoietic CD34+ Cells. JEM
197: 763-775
[Abstract]
[Full Text]
-
Shi, Y., Gera, J., Hu, L., Hsu, J.-h., Bookstein, R., Li, W., Lichtenstein, A.
(2002). Enhanced Sensitivity of Multiple Myeloma Cells Containing PTEN Mutations to CCI-779. Cancer Res.
62: 5027-5034
[Abstract]
[Full Text]
-
Navarro, M., Valentinis, B., Belletti, B., Romano, G., Reiss, K., Baserga, R.
(2001). Regulation of Id2 Gene Expression by the Type 1 IGF Receptor and the Insulin Receptor Substrate-1. Endocrinology
142: 5149-5157
[Abstract]
[Full Text]
-
Prisco, M., Peruzzi, F., Belletti, B., Baserga, R.
(2001). Regulation of Id Gene Expression by Type I Insulin-Like Growth Factor: Roles of STAT3 and the Tyrosine 950 Residue of the Receptor. Mol. Cell. Biol.
21: 5447-5458
[Abstract]
[Full Text]
-
Boney, C. M., Sekimoto, H., Gruppuso, P. A., Frackelton, A. R. Jr.
(2001). Src Family Tyrosine Kinases Participate in Insulin-like Growth Factor I Mitogenic Signaling in 3T3-L1 Cells. Cell Growth Differ.
12: 379-386
[Abstract]
[Full Text]
-
Valentinis, B, Baserga, R
(2001). IGF-I receptor signalling in transformation and differentiation. Mol. Pathol.
54: 133-137
[Abstract]
[Full Text]
-
Navarro, M., Baserga, R.
(2001). Limited Redundancy of Survival Signals from the Type 1 Insulin-Like Growth Factor Receptor. Endocrinology
142: 1073-1081
[Abstract]
[Full Text]
-
Hyun, T., Yam, A., Pece, S., Xie, X., Zhang, J., Miki, T., Gutkind, J. S., Li, W.
(2000). Loss of PTEN expression leading to high Akt activation in human multiple myelomas. Blood
96: 3560-3568
[Abstract]
[Full Text]
-
Li, W., Hyun, T., Heller, M., Yam, A., Flechner, L., Pierce, J. H., Rudikoff, S.
(2000). Activation of Insulin-like Growth Factor I Receptor Signaling Pathway Is Critical for Mouse Plasma Cell Tumor Growth. Cancer Res.
60: 3909-3915
[Abstract]
[Full Text]
-
Boney, C. M., Gruppuso, P. A., Faris, R. A., Frackelton, A. R. Jr.
(2000). The Critical Role of Shc in Insulin-Like Growth Factor-I-Mediated Mitogenesis and Differentiation in 3T3-L1 Preadipocytes. Mol. Endocrinol.
14: 805-813
[Abstract]
[Full Text]
-
Dews, M., Prisco, M., Peruzzi, F., Romano, G., Morrione, A., Baserga, R.
(2000). Domains of the Insulin-Like Growth Factor I Receptor Required for the Activation of Extracellular Signal-Regulated Kinases. Endocrinology
141: 1289-1300
[Abstract]
[Full Text]
-
Burtscher, I., Compagni, A., Lamm, G. M., Christofori, G.
(1999). An Insulin-like Growth Factor-mediated, Phosphatidylinositol 3' Kinase-independent Survival Signaling Pathway in {beta} Tumor Cells. Cancer Res.
59: 3923-3926
[Abstract]
[Full Text]
-
Valentinis, B., Navarro, M., Zanocco-Marani, T., Edmonds, P., McCormick, J., Morrione, A., Sacchi, A., Romano, G., Reiss, K., Baserga, R.
(2000). Insulin Receptor Substrate-1, p70S6K, and Cell Size in Transformation and Differentiation of Hemopoietic Cells. J. Biol. Chem.
275: 25451-25459
[Abstract]
[Full Text]
-
Yam, A., Hyun, T., Li, W.
(2001). Characterization of Insulin-like Growth Factor I (IGF-I) Receptor Mutants for Their Effects on IGF-I- and Interleukin 4-mediated DNA Synthesis of 32D Cells. J. Biol. Chem.
276: 24409-24413
[Abstract]
[Full Text]
-
Peruzzi, F., Prisco, M., Morrione, A., Valentinis, B., Baserga, R.
(2001). Anti-apoptotic Signaling of the Insulin-like Growth Factor-I Receptor through Mitochondrial Translocation of c-Raf and Nedd4. J. Biol. Chem.
276: 25990-25996
[Abstract]
[Full Text]